{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:40:31Z","timestamp":1757612431804,"version":"3.44.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,18]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Inflammation of unknown origin (IUO) in elderly patients is frequently caused by noninfectious inflammatory diseases. When infections and malignancies are ruled out, glucocorticoids (GCs) are often administered as an empirical diagnostic treatment. However, GC carries risks, including osteoporosis and venous thromboembolism (VTE), and in cases of undiagnosed malignancies, GC use may delay definitive diagnosis. Additionally, VTE itself can mimic IUO by inducing inflammation, making diagnosis more complex when multiple conditions coexist. Despite these concerns, comprehensive studies on the risks of empirical GC treatment for IUO are lacking. This case highlights these potential risks.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>An 84-year-old Japanese woman with no prior medical history presented with a 5-month history of fever and anorexia without identifiable causes. She exhibited persistently elevated C-reactive protein levels, and initial antimicrobial therapy was ineffective.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>The patient was initially suspected of having noninfectious inflammatory diseases. However, after experiencing complications from GC therapy, further investigations revealed Stage I gastric adenocarcinoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Two weeks after hospital admission, prednisolone 30\u2009mg\/day was initiated for suspected noninfectious inflammatory diseases, leading to normalization of C-reactive protein. However, upon GC reduction, the inflammatory markers increased again, necessitating continued prednisolone administration. The patient subsequently developed a compression fracture and was later readmitted with right leg edema and pain. Imaging revealed VTE, likely resulting from GC use and immobilization from the fracture. Anticoagulation therapy was initiated, and GC tapering was performed. Despite persistent inflammation, further diagnostic evaluations, including F-fluorodeoxyglucose positron emission tomography\/computed tomography, revealed hyperaccumulation in the stomach, leading to endoscopic confirmation of Stage I gastric adenocarcinoma. The patient underwent laparoscopy-assisted distal gastrectomy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>One year after surgery, no recurrence of malignancy was observed. The patient\u2019s inflammatory markers normalized, and no further thromboembolic events were observed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This case demonstrates that GC therapy in elderly IUO patients can lead to severe complications, including VTE, and delayed malignancy diagnosis. Thorough malignancy and thrombus screening should be conducted before GC initiation. Additionally, when VTE occurs in IUO patients, malignancy should be reassessed, even if other risk factors are present. This case underscores the importance of caution when considering empirical GC therapy for IUO.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000042234","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T11:01:33Z","timestamp":1746529293000},"page":"e42234","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Risks of empiric glucocorticoid administration in elderly patients with inflammation of unknown origin: A case report"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5053-5933","authenticated-orcid":false,"given":"Takashi","family":"Yamane","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Kakogawa Central City Hospital, Kakogawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiharu","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Kakogawa Central City Hospital, Kakogawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250904","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2169\/internalmedicine.53.2218","article-title":"Analysis of 256 cases of classic fever of unknown origin.","volume":"53","author":"Yamanouchi","year":"2014","journal-title":"Intern Med"},{"key":"R2-20250904","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/annrheumdis-2017-211687","article-title":"The value of 18F-FDG-PET\/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study.","volume":"77","author":"Sch\u00f6nau","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R3-20250904","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/03009742.2023.2215044","article-title":"Differential diagnostics of polymyalgia rheumatica in a university hospital in Finland.","volume":"52","author":"Paltta","year":"2023","journal-title":"Scand J Rheumatol"},{"key":"R4-20250904","first-page":"2179","article-title":"The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain.","volume":"27","author":"Gonzalez-Gay","year":"2000","journal-title":"J Rheumatol"},{"key":"R5-20250904","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41569-022-00787-6","article-title":"Epidemiology and prevention of venous thromboembolism.","volume":"20","author":"Lutsey","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"R6-20250904","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","article-title":"Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.","volume":"173","author":"Johannesdottir","year":"2013","journal-title":"JAMA Intern Med"},{"key":"R7-20250904","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/bjh.17388","article-title":"Glucocorticoid use and risk of first and recurrent venous thromboembolism: self-controlled case-series and cohort study.","volume":"193","author":"Orsi","year":"2021","journal-title":"Br J Haematol"},{"key":"R8-20250904","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1378\/chest.12-1446","article-title":"Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study.","volume":"143","author":"Stuijver","year":"2013","journal-title":"Chest"},{"key":"R9-20250904","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12959-023-00526-y","article-title":"Association between inflammatory biomarkers and venous thromboembolism: a systematic review and meta-analysis.","volume":"21","author":"Ding","year":"2023","journal-title":"Thromb J"},{"key":"R10-20250904","doi-asserted-by":"crossref","first-page":"e889","DOI":"10.1002\/ams2.889","article-title":"The impact of fever as a testing indication on the detection rate of deep vein thrombosis in neurocritically ill patients.","volume":"10","author":"Henson","year":"2023","journal-title":"Acute Med Surg"},{"key":"R11-20250904","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0140-6736(95)92535-X","article-title":"Accuracy of clinical assessment of deep-vein thrombosis.","volume":"345","author":"Wells","year":"1995","journal-title":"Lancet"},{"key":"R12-20250904","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7326\/0003-4819-143-2-200507190-00012","article-title":"Meta-analysis: the value of clinical assessment in the diagnosis of deep venous thrombosis.","volume":"143","author":"Goodacre","year":"2005","journal-title":"Ann Intern Med"},{"key":"R13-20250904","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/jamainternmed.2015.1687","article-title":"Performance of Wells score for deep vein thrombosis in the inpatient setting.","volume":"175","author":"Silveira","year":"2015","journal-title":"JAMA Intern Med"},{"key":"R14-20250904","first-page":"406","article-title":"The role of molecular imaging in diagnosis of deep vein thrombosis.","volume":"4","author":"Houshmand","year":"2014","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"R15-20250904","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.amjsurg.2022.11.031","article-title":"The long-term risks of venous thromboembolism among non-operatively managed spinal fracture patients: a nationwide analysis.","volume":"225","author":"Avila","year":"2023","journal-title":"Am J Surg"},{"key":"R16-20250904","first-page":"745","article-title":"Prevalence and screening of deep vein thrombosis in patients with osteoporotic vertebral fracture.","volume":"31","author":"Miura","year":"2021","journal-title":"Turk Neurosurg"},{"key":"R17-20250904","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.chest.2024.03.003","article-title":"Antithrombotic therapy for VTE disease: compendium and review of CHEST guidelines 2012-2021.","volume":"166","author":"Stevens","year":"2024","journal-title":"Chest"},{"key":"R18-20250904","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/rheumatology\/keab675","article-title":"2-deoxy-2[18F]fluoro-D-glucose positron emission tomography-computed tomography in rheumatological diseases.","volume":"61","author":"Subesinghe","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"R19-20250904","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1007\/s10067-023-06673-x","article-title":"Rheumatology experience with FDG PET\/CT in inflammation of unknown origin: a single-centre report for determining factors associated with diagnostic precision.","volume":"42","author":"Aky\u00fcz Da\u011fli","year":"2023","journal-title":"Clin Rheumatol"},{"key":"R20-20250904","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejim.2021.07.014","article-title":"The yield of F18 FDG PET-CT for the investigation of fever of unknown origin, compared with diagnostic CT.","volume":"93","author":"Buchrits","year":"2021","journal-title":"Eur J Intern Med"},{"key":"R21-20250904","doi-asserted-by":"crossref","first-page":"55765","DOI":"10.18632\/oncotarget.9910","article-title":"Elevated serum C-reactive protein level predicts a poor prognosis for recurrent gastric cancer.","volume":"7","author":"Kong","year":"2016","journal-title":"Oncotarget"},{"key":"R22-20250904","doi-asserted-by":"crossref","first-page":"e0143080","DOI":"10.1371\/journal.pone.0143080","article-title":"C-reactive protein is an important biomarker for prognosis, tumor recurrence, and treatment response in adult solid tumors: a systematic review.","volume":"10","author":"Shrotriya","year":"2015","journal-title":"PLoS One"},{"key":"R23-20250904","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.3390\/ijms24043169","article-title":"A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology.","volume":"24","author":"Pastori","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R24-20250904","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jvsv.2022.05.014","article-title":"Venous thromboembolism as the first sign of malignancy.","volume":"10","author":"Pandit","year":"2022","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"R25-20250904","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/CIRCULATIONAHA.114.008902","article-title":"18F-fluorodeoxyglucose positron emission tomography\/computed tomography enables the detection of recurrent same-site deep vein thrombosis by illuminating recently formed, neutrophil-rich thrombus.","volume":"130","author":"Hara","year":"2014","journal-title":"Circulation"},{"key":"R26-20250904","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/RLU.0000000000000453","article-title":"Efficacy of FDG PET\/CT imaging for venous thromboembolic disorders: preliminary results from a prospective, observational pilot study.","volume":"40","author":"Hess","year":"2015","journal-title":"Clin Nucl Med"},{"key":"R27-20250904","first-page":"66","article-title":"The application of 18F-FDG-PET\/CT in gastric cancer staging and factors affecting its sensitivity.","volume":"24","author":"D\u0119biec","year":"2021","journal-title":"Hell J Nucl Med"},{"key":"R28-20250904","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11604-014-0294-0","article-title":"Performance profile of an FDG-PET cancer screening program for detecting gastric cancer: results from a nationwide Japanese survey.","volume":"32","author":"Minamimoto","year":"2014","journal-title":"Jpn J Radiol"},{"key":"R29-20250904","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/ard-2023-225134","article-title":"Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica study group.","volume":"83","author":"Keller","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"R30-20250904","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/rheumatology\/keac713","article-title":"An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists.","volume":"62","author":"Donskov","year":"2023","journal-title":"Rheumatology (Oxford)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042234","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T12:01:00Z","timestamp":1756987260000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":30,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042234","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,4,18]]}}}